UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 75

Sortiert nach

Reduction of direct and indirect costs in patients with AS receiving etanercept: results from an open-label 36-week extension of the ASCEND study in four European countries

Rheumatology (Oxford, England), 2012-02, Vol.51 (2), p.393-396

2012

Link zum Volltext

Verfügbarkeit prüfen

Sex Differences in the Effectiveness of First‐Line Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis: Results From the European Spondyloarthritis Research Collaboration Network

Arthritis & rheumatology (Hoboken, N.J.), 2024-04, Vol.76 (4), p.587-598

2024

Link zum Volltext

Verfügbarkeit prüfen

Real‐World Six‐ and Twelve‐Month Drug Retention, Remission, and Response Rates of Secukinumab in 2,017 Patients With Psoriatic Arthritis in Thirteen European Countries

Arthritis care & research (2010), 2022-07, Vol.74 (7), p.1205-1218

2022

Link zum Volltext

Verfügbarkeit prüfen

Surfactant protein-D, a potential mediator of inflammation in axial spondyloarthritis

Rheumatology (Oxford, England), 2018-10, Vol.57 (10), p.1861-1865

2018

Link zum Volltext

Verfügbarkeit prüfen

Sex differences in the effectiveness of first-line tumour necrosis factor inhibitors in axial spondyloarthritis: results from the EuroSpA Research Collaboration Network

Rheumatic & musculoskeletal diseases open, 2023-12, Vol.9 (4), p.e003325

2023

Link zum Volltext

Verfügbarkeit prüfen

Sex differences in patient-reported outcomes and the association with clinical factors in axial spondyloarthritis patients treated with tumour necrosis factor inhibitors

Rheumatology (Oxford, England), 2024-07

2024

Link zum Volltext

Verfügbarkeit prüfen

Reduction of direct and indirect costs in patients with AS receiving etanercept: results from an open-label 36-week extension of the ASCEND study in four European countries: Themed Issue on Rheumatology and Work

Rheumatology (Oxford, England), 2012, Vol.51 (2), p.393-396

2012

Link zum Volltext

Verfügbarkeit prüfen

Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study

The lancet. Diabetes & endocrinology, 2019-12, Vol.7 (12), p.899-911

2019

Link zum Volltext

Verfügbarkeit prüfen

Two successful pregnancies following autotransplantation of frozen/thawed ovarian tissue

Human reproduction (Oxford), 2008-10, Vol.23 (10), p.2266-2272

2008

Link zum Volltext

Verfügbarkeit prüfen

The KDM5 family is required for activation of pro-proliferative cell cycle genes during adipocyte differentiation

Nucleic acids research, 2017-02, Vol.45 (4), p.1743

2017

Link zum Volltext

Verfügbarkeit prüfen

A Phase 3 Trial of Bevacizumab in Ovarian Cancer

The New England journal of medicine, 2011-12, Vol.365 (26), p.2484-2496

2011

Link zum Volltext

Verfügbarkeit prüfen

Pulmonary exposure to carbon black by inhalation or instillation in pregnant mice: Effects on liver DNA strand breaks in dams and offspring

Nanotoxicology, 2012-08, Vol.6 (5), p.486-500

2012

Link zum Volltext

Verfügbarkeit prüfen

Health effects of exposure to diesel exhaust in diesel-powered trains

Particle and fibre toxicology, 2019-06, Vol.16 (1), p.21-14, Article 21

2019

Link zum Volltext

Verfügbarkeit prüfen

Obstetric and neonatal outcome after oocyte donation in 106 women with Turner syndrome: a Nordic cohort study

Human reproduction (Oxford), 2013-06, Vol.28 (6), p.1598-1609

2013

Link zum Volltext

Verfügbarkeit prüfen

Exposure to Air Pollution inside Electric and Diesel-Powered Passenger Trains

Environmental science & technology, 2019-04, Vol.53 (8), p.4579-4587

2019

Link zum Volltext

Verfügbarkeit prüfen

Type I and III collagen turnover is increased in axial spondyloarthritis and psoriatic arthritis. Associations with disease activity and diagnostic capacity

Clinical and experimental rheumatology, 2017-07, Vol.35 (4), p.653

2017

Link zum Volltext

Verfügbarkeit prüfen

Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: Data from the EuroSpA collaboration

Seminars in arthritis and rheumatism, 2022-10, Vol.56, p.152081, Article 152081

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 75

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(70)
Mit Volltextzugriff
(62)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Reduction of direct and indirect costs in patients with AS receiving etanercept: results from an open-label 36-week extension of the ASCEND study in four European countries

Sex Differences in the Effectiveness of First‐Line Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis: Results From the European Spondyloarthritis Research Collaboration Network

Real‐World Six‐ and Twelve‐Month Drug Retention, Remission, and Response Rates of Secukinumab in 2,017 Patients With Psoriatic Arthritis in Thirteen European Countries

Patient-Reported Outcomes (PROs) and PRO Remission Rates in 12,262 Biologic-Naïve Patients With Psoriatic Arthritis Treated With Tumor Necrosis Factor Inhibitors in Routine Care

Ankylosing Spondylitis versus Nonradiographic Axial Spondyloarthritis: Comparison of Tumor Necrosis Factor Inhibitor Effectiveness and Effect of HLA-B27 Status. An Observational Cohort Study from the Nationwide DANBIO Registry

Surfactant protein-D, a potential mediator of inflammation in axial spondyloarthritis

Sex differences in the effectiveness of first-line tumour necrosis factor inhibitors in axial spondyloarthritis: results from the EuroSpA Research Collaboration Network

Sex differences in patient-reported outcomes and the association with clinical factors in axial spondyloarthritis patients treated with tumour necrosis factor inhibitors

Reduction of direct and indirect costs in patients with AS receiving etanercept: results from an open-label 36-week extension of the ASCEND study in four European countries: Themed Issue on Rheumatology and Work

Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study

Two successful pregnancies following autotransplantation of frozen/thawed ovarian tissue

The KDM5 family is required for activation of pro-proliferative cell cycle genes during adipocyte differentiation

A Phase 3 Trial of Bevacizumab in Ovarian Cancer

Pulmonary exposure to carbon black by inhalation or instillation in pregnant mice: Effects on liver DNA strand breaks in dams and offspring

Health effects of exposure to diesel exhaust in diesel-powered trains

Ambient air pollution and primary liver cancer incidence in four European cohorts within the ESCAPE project

Obstetric and neonatal outcome after oocyte donation in 106 women with Turner syndrome: a Nordic cohort study

Exposure to Air Pollution inside Electric and Diesel-Powered Passenger Trains

Retention and response rates in 14 261 PsA patients starting TNF inhibitor treatment—results from 12 countries in EuroSpA

Streamflow droughts aggravated by human activities despite management

Type I and III collagen turnover is increased in axial spondyloarthritis and psoriatic arthritis. Associations with disease activity and diagnostic capacity

Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF inhibitor: results from 13 European registries

Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: Data from the EuroSpA collaboration

Validity and completeness of rheumatoid arthritis diagnoses in the nationwide DANBIO clinical register and the Danish National Patient Registry

Suchergebnisse filtern